Wei Zhai

2.7k total citations
80 papers, 1.7k citations indexed

About

Wei Zhai is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei Zhai has authored 80 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 34 papers in Cancer Research and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei Zhai's work include Renal cell carcinoma treatment (20 papers), Renal and related cancers (13 papers) and Cancer-related molecular mechanisms research (12 papers). Wei Zhai is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Renal and related cancers (13 papers) and Cancer-related molecular mechanisms research (12 papers). Wei Zhai collaborates with scholars based in China, United States and Taiwan. Wei Zhai's co-authors include Wei Xue, Yunfei Xu, E.D. Peebles, Junjie Ma, Guanghui Hu, Junhua Zheng, Dongkui Gong, Yonghui Chen, D. E. Rowe and Chawnshang Chang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Oncogene.

In The Last Decade

Wei Zhai

77 papers receiving 1.7k citations

Peers

Wei Zhai
Yanlei Li China
Xuemei Li China
Lei Cao China
Yan Liang China
Chen Qu China
Yanlei Li China
Wei Zhai
Citations per year, relative to Wei Zhai Wei Zhai (= 1×) peers Yanlei Li

Countries citing papers authored by Wei Zhai

Since Specialization
Citations

This map shows the geographic impact of Wei Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zhai more than expected).

Fields of papers citing papers by Wei Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zhai. The network helps show where Wei Zhai may publish in the future.

Co-authorship network of co-authors of Wei Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Zhai. A scholar is included among the top collaborators of Wei Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Zhai. Wei Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hui, Jing Dai, Wenjing Chen, et al.. (2025). OTUD3-mediated stabilization of SLC7A11 drives sunitinib resistance by suppressing ferroptosis in clear cell renal cell carcinoma. Cancer Letters. 632. 217942–217942. 1 indexed citations
2.
Zhang, Yan, X.L. Chen, Junjie Xiao, et al.. (2025). Resilience measurement and enhancement of population mobility network in Beijing-Tianjin-Hebei urban agglomeration under extreme rainfall impact. Journal of Transport Geography. 126. 104253–104253. 1 indexed citations
3.
Zhai, Wei, Xiaodan Li, Tengfei Zhou, et al.. (2025). A machine learning-based 18F-FDG PET/CT multi-modality fusion radiomics model to predict Mediastinal-Hilar lymph node metastasis in NSCLC: a multi-centre study. Clinical Radiology. 83. 106832–106832. 1 indexed citations
4.
Wang, Yiqiu, Ding Zhao, Jiayi Lu, et al.. (2025). The molecular axis hnRNPU/circKCNK2/EDC4/IL-11 aggravates osteolytic bone metastasis of RCC. Oncogene. 44(36). 3310–3332. 2 indexed citations
5.
Liu, Shuhong, et al.. (2024). Experimental investigation on phase equilibria of the Nd-Y and Nd-Y-Fe systems. Calphad. 88. 102788–102788. 4 indexed citations
6.
Zhai, Shuo, Wanshan Liu, Wanwan Liu, et al.. (2024). Serum and Urine Metabolic Fingerprints Characterize Renal Cell Carcinoma for Classification, Early Diagnosis, and Prognosis. Advanced Science. 11(34). e2401919–e2401919. 8 indexed citations
7.
Huang, Jiwei, Fan Xu, Wen Kong, et al.. (2024). Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial. Journal for ImmunoTherapy of Cancer. 12(6). e008475–e008475. 4 indexed citations
8.
Chen, Tianyi, Xiaorong Wu, Wen Kong, et al.. (2023). Serum extracellular vesicles derived hsa-miR-320d as an indicator for progression of clear cell renal cell carcinoma. Discover Oncology. 14(1). 114–114. 3 indexed citations
9.
Wang, Yiqiu, Xinyi Zheng, Wenjie Huang, et al.. (2023). Loss of MIR503HG facilitates papillary renal cell carcinoma associated lymphatic metastasis by triggering NOTCH1/VEGFC signaling. International Journal of Biological Sciences. 19(10). 3266–3284. 5 indexed citations
10.
Guo, Chuanyong, Yin Sun, Wei Zhai, et al.. (2022). Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis. Cell & Bioscience. 12(1). 185–185. 8 indexed citations
11.
Zhai, Wei, et al.. (2022). Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma. Frontiers in Immunology. 13. 902060–902060. 10 indexed citations
12.
Gong, Dongkui, Yin Sun, Chuanyong Guo, et al.. (2021). Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis. SHILAP Revista de lepidopterología. 11(3). 27 indexed citations
13.
Huang, Chi, Guanghui Hu, Junjie Ma, et al.. (2020). Tumor-educated B cells promote renal cancer metastasis via inducing the IL-1β/HIF-2α/Notch1 signals. Cell Death and Disease. 11(3). 163–163. 30 indexed citations
14.
Zhai, Wei, et al.. (2020). Bioinformatic gene analysis for potential biomarkers and therapeutic targets of diabetic nephropathy associated renal cell carcinoma. Translational Andrology and Urology. 9(6). 2555–2571. 8 indexed citations
15.
Zhai, Wei, Junjie Ma, Rujian Zhu, et al.. (2018). MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis. British Journal of Cancer. 119(5). 591–604. 63 indexed citations
16.
Chen, Chen, Sheng Xue, Jin Zhang, et al.. (2017). DNA‐methylation‐mediated repression of miR‐766‐3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma. International Journal of Cancer. 141(9). 1867–1878. 51 indexed citations
18.
Sun, Xiaochun, Min Sun, Yan Xie, et al.. (2013). Cytotoxic effects of acrylonitrile on human umbilical cord mesenchymal stem cells in vitro. Molecular Medicine Reports. 9(1). 97–102. 4 indexed citations
19.
Liu, Min, Yongzhen Liu, Wei Li, et al.. (2013). Preventive effect of phosphodiesterase 5 inhibitor Tadalafil on experimental post-pyelonephritic renal injury in rats. Journal of Surgical Research. 186(1). 253–261. 10 indexed citations
20.
Corzo, A., et al.. (2010). Effects of in ovo injection of L-carnitine on hatchability and subsequent broiler performance and slaughter yield. Poultry Science. 89(7). 1497–1501. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026